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A high degree of sequence homology has been found between the N-terminal region of histidine-rich glyco- 
protein (HRG) and that of antithrombin III (AT III) where the putative heparin-binding site of AT III 
is located. The amino acid residue at the position corresponding toArg-47 of AT III that is essential for 
the heparin-binding was also arginine (Arg 23 and 78) in the homologous sequences of HRG. These obser- 
vations trongly suggest that the heparin-binding sites of HRG and AT III are evolutionarily related. There 
was no apparent sequence similarity between the remaining about 70% portions of the two proteins. 
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1. INTRODUCTION binding [6], supporting the original suggestion [5]. 
Antithrombin III (AT III) and histidine-rich 
glycoprotein (HRG) are plasma glycoproteins that 
have a high affinity for heparin. The importance 
of heparin-accelerated anticoagulant activity 
(heparin-cofactor activity) of AT III has been well 
recognized by the observation that a congenital 
defect of AT III having normal antithrombin ac- 
tivity but no heparin-binding ability results in 
recurrent thrombophlebitis [l]. It has also been 
suggested that the heparin-binding property of 
HRG may be of physiological importance as a 
modulator of AT III and heparin cofactor II 
[2-41. 
Recently, the complete amino acid sequence of 
human HRG has been determined by cDNA clon- 
ing [7]. Here, the expanded N-terminal sequence of 
HRG (residues 1-146) is shown to be highly 
homologous with the N-terminal region of AT III. 
This region includes the heparin-binding site of 
AT III and strongly suggests that arginine present 
in the same position in HRG as in AT III is also in- 
volved in heparin binding. 
2. RESULTS AND DISCUSSION 
In [5], we reported that the N-terminal 22 amino 
acid sequence of HRG is homologous to that of 
AT III, and suggested that the putative heparin- 
binding sites of the 2 proteins were located in the 
N-terminal region of each protein. We also showed 
that Arg 47 of AT III is essential for heparin 
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Fig.1 shows a comparison of the amino acid se- 
quences of HRG (residues l-64 and 65-146) and 
AT III (residues 24-139). The residues that are 
identical or conserved between HRG and AT III 
are shown in blocks. In comparing the N-terminal 
region (residues l-64) of HRG with AT III, 27 
residues out of 67 were either identical or highly 
conserved (40% homology). A comparison of 
residues 65-146 of HRG with AT III showed that 
43 residues out of 117 were identical or conserved 
(37% homology). There was no apparent 
homology in the remaining portion (70%) of the 2 
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Fig.1. Comparison of the amino acid sequences of HRG and AT III. HRG, histidine-rich glycoprotein [5,7], AT 3, 
antithrombin III [13-161. The numbers in parentheses are residue number in sequence of each protein. Identical or 
conserved residues between HRG and AT 3 are enclosed in boxes. Gaps are included for the best alignment. An arrow 
shows Arg 47 that has been replaced by cysteine in ‘Antithrombin III Toyama’ [6]. Single-letter code for amino acids: 
Ala, A; Arg, R; Asn, N; Asp, D; Cys, C; Gln, Q; Glu, E; Gly, G; His, H; Ile, I; Leu, L; Lys, K; Met, M; Phe, F; 
Pro, P; Ser, S; Thr, T; Trp, W; Tyr, Y; Val, V. 
proteins. These results extend our previous obser- 
vation that these 2 proteins are highly homologous 
in their N-terminal regions [5]. 
Recently, the structural abnormality of an- 
tithrombin III Toyama was shown to be due to a 
lack of heparin-binding ability and this was due to 
a replacement of Arg 47 by cysteine [6]. These data 
provided good evidence to support the concept 
that Arg 47 was an essential residue for heparin 
binding to AT III. A striking feature of the present 
sequence homology between HRG and AT III is 
that Arg 47 is present in a homologous position in 
both proteins. Furthermore, there are 2 arginine 
residues (Arg 23 and Arg 78) in HRG that are 
aligned at this position. These observations uggest 
that there could be 2 heparin-binding sites in HRG. 
However, there is a large deletion just prior to Arg 
78 (between Ser 76 and Arg 77) in this alignment. 
The interaction between each of these proteins 
and heparin probably involves one or more of the 
negatively charged sulfate groups in the penta- to 
octasaccharide units in the heparin molecule that 
are important for its binding to AT III [8-lo]. 
Therefore, it is also likely that in addition to Arg 
47, several additional positively charged groups in 
AT III may participate in its interaction with 
heparin. From the sequence homology between 
HRG and AT III, it may be possible that Lys 39, 
Arg 46 and Arg 57 of AT III, and by analogy, Lys 
15, Lys 22, Arg 23, Arg 34, Arg 76, Arg 77 and Lys 
87 of HRG are also involved in the binding of 
heparin. 
In spite of the high sequence homology of these 
2 proteins at their N-terminal regions, there was no 
apparent sequence similafity between the remain- 
ing portions of the 2 proteins. In the C-terminal 
portion of AT III there is a high homology with 
cui-antitrypsin, cui-antichymotrypsin and oval- 
bumin [ 11,121. These observations trongly suggest 
that HRG and AT III are evolutionarily related 
only in their heparin-binding region or domain. 
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